Surya Patra, pharma analyst at Phillip Capital now estimates IPCA's institutional revenues to fall to around Rs 200 crore, from its earlier estimate of around Rs 260 crore
first published: Apr 8, 2016 09:13 am
A collection of the most-viewed Moneycontrol videos.

Live: Will Nifty's weakness continue for the second straight day? | Opening Bell

A money superpower you have in your 20s, not in 40s

Live: Nifty snaps 3-day gaining streak, slips below 26,300 on Venezuela tensions | Closing Bell

Live: Will US-Venezuela tensions derail Nifty's upmove? | Oil stocks in focus | Opening Bell
You are already a Moneycontrol Pro user.

